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Abstract
Background: Maternal mortality in South Africa is rising, and heart conditions currently account for 41 per cent of
indirect causes of deaths. Little is known about the burden of heart disease in pregnant South Africans.
Methods: We systematically reviewed the contemporary epidemiology and peripartum outcomes of heart disease
in South African women attending antenatal care. Searches were performed in PubMed, ISI Web of Science, the
EBSCO Africa-Wide database, the South African Union Catalogue, and the Current and Completed Research
database (South Africa). References of included articles were also hand-searched. Studies reporting epidemiologic
data on antenatal heart disease in South Africa were included. Data on morbidity and mortality were also
collected.
Results: Seven studies were included in the systematic review. The prevalence of heart disease ranged from 123 to
943 per 100,000 deliveries, with a median prevalence of 616 per 100,000. Rheumatic valvular lesions were the
commonest abnormalities, although cardiomyopathies were disproportionately high in comparison with other
developing countries. Peripartum case-fatality rates were as high as 9.5 per cent in areas with limited access to
care. The most frequent complications were pulmonary oedema, thromboembolism, and major bleeding with
warfarin use. Perinatal mortality ranged from 8.9 to 23.8 per cent, whilst mitral lesions were associated with low
birth weight. Meta-analysis could not be performed due to clinical and statistical heterogeneity of the included
studies.
Conclusion: Approximately 0.6 per cent of pregnant South Africans have pre-existing cardiac abnormalities, with
rheumatic lesions being the commonest. Maternal and perinatal morbidity and mortality continue to be very high.
We conclude this review by summarising limitations of the current literature and recommending standard
reporting criteria for future reports.
Background
Globally, complications of heart disease during preg-
nancy account for a substantial proportion of maternal
morbidity and mortality [1]. Physiological increases in
blood volume, heart rate, and cardiac output occur in
pregnancy but can exacerbate underlying cardiac condi-
tions, particularly during the latter half of the pregnancy
[2]. The prevalence of pre-existing heart disease
amongst pregnant women worldwide varies but has
been reported to range from 0.9 to 3.7 per cent [3].
Whereas congenital abnormalities are the commonest
abnormalities found in pregnant women from industria-
lised regions, rheumatic heart disease still predominates
in poorer countries [4].
South Africa is in the midst of an epidemiologic tran-
sition with a high burden of both cardiac diseases of
poverty such as rheumatic heart disease (RHD) and
chronic, non-communicable diseases such as hyperten-
sion [5]. Whilst the profile of cardiovascular disease is
changing, maternal mortality in South Africa has quad-
rupled over the past decade, in part due to an ineffective
health system [6]. The Ministry of Health’s most recent
survey on maternal deaths (2005-2007) found that,
amongst “indirect” causes of death, heart diseases
account for 41 per cent of cases. Seventy-seven percent
of maternal deaths from cardiac disease occurred in
those attending antenatal care, highlighting the need for
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existing heart disease [7].
Studies on the prevalence and outcome of heart dis-
eases in pregnant South Africans (referred to as “antena-
tal heart disease” in this review) have reported varied
findings depending on the times and settings in which
they were performed. The primary objective of this
review is to estimate the prevalence of cardiac disease
during pregnancy and profile the various lesions that
commonly afflict patients. The secondary objective of
this review is to summarise maternal and foetal out-
comes in this population.
Methods
Inclusion and exclusion criteria
Any study investigating antenatal heart diseases in preg-
nant South African women was considered for review.
In order to obtain the best epidemiological data, only
studies that were designed to measure hospital- or com-
munity-based burden of heart disease were included in
the final analysis. Studies were excluded if they did not
provide any information regarding a reference popula-
tion of pregnant women without heart disease. The
review was limited to studies conducted in participants
over 18 years of age. Although we secondarily collected
data on maternal and foetal outcomes, studies were not
included or excluded on this basis. Language of publica-
tion was restricted to English articles only. Editorials
and review articles were excluded.
Search strategy
Two independent reviewers (DAW and MS) reviewed
lists of articles obtained from several databases relevant
to the South African population. The pre-specified
search strategy for each database was as follows: MED-
LINE was searched with the term “Heart Diseases"[-
MeSH] AND pregnan*[TIAB] AND “South Africa"[All
Fields]; ISI Web of Science was searched with the term
TS = HEART DISEASE (and) TS = PREGNAN* (and)
CU = SOUTH AFRICA; and the EBSCO Africa-Wide
database was searched with the term SU = heart or car-
diac or cardiovascular (and) TI = disease* (and) SU =
pregnan* (and) TX = South Africa. To search for South
African conference proceedings, theses, and abstracts,
two internal databases at the University of Cape Town
Health Sciences Library were searched. Current and
Completed Research (South Africa) [8] was searched
using “heart AND pregnancy” and the South African
Union Catalogue (SACat) section on South African The-
ses [8] was searched using the term ("heart” OR “car-
diac”)A N D“pregnancy.” All databases were accessed
during the month of March 2011. Articles were selected
on the basis of relevant title with relevant abstract and
full text articles were obtained from potentially eligible
reports. In the final stage of the search, reference lists of
full-text articles were hand-searched. Discrepancies were
resolved by consensus discussion between the two
reviewers with adjudication by the senior author (BMM)
as necessary.
Data extraction
Two reviewers (DAW and MS) used a standardised data
extraction form to obtain information on study design,
patient demographics, and total numbers of each cardiac
lesion. Secondarily, basic information was obtained on
the rates of specific outcomes: maternal death, pulmon-
ary oedema, thrombosis, haemorrhage, and foetal
demise. Again, discrepancies were adjudicated by con-
sensus discussion between the two reviewers with the
assistance of the senior author (BMM) as necessary.
When study data were incomplete or contradictory with
regard to the primary objective, the original author of
the manuscript was contacted to clarify his or her
findings.
Statistical terminology and analysis
Prevalences, case-fatality rates, and when applicable,
perinatal mortality rates, are expressed per standard
100,000 deliveries. In hospital-based series and cohorts,
we have reported the “prevalence” of antenatal heart dis-
ease as the number of patients in the study (all with
heart disease) divided by the total number of deliveries
at the institution, multiplied by 100,000. In some
reports, cases of heart disease were reported in terms of
“incidence"; however as most of the cardiac lesions likely
predated pregnancy, we felt this term to be imprecise.
We have also reported death rates as case-fatality in
spite of the fact that papers tended to use the term
“maternal mortality” because in our assessment, deaths
were almost exclusively due to complications of the car-
diac lesion (e.g., pulmonary oedema or coagulopathies
related to warfarin misuse). We report “perinatal mortal-
ity” as any stillbirth, peripartum or neonatal death (i.e.,
less than 1 month). Unfortunately some studies did not
have full records for all patients [9,10] and thus, we ana-
lysed perinatal deaths in a subset of women with cardiac
disease, likely inflating mortality rates. We intended to
perform a meta-analysis in an attempt to provide an
aggregate of the prevalence data from the included stu-
dies. All reported numerical data were stored and ana-
lysed using Microsoft Excel 2010.
Results
Search results and study characteristics
The search strategy and numerical results of the article
selection process are shown in the flow diagram in Fig-
ure 1. MEDLINE retrieved 29 titles, ISI Web of Science
35 titles, EBSCO 18 titles, Current and Completed
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Africa Catalogue) 3 titles. After screening the titles iden-
tified through the search and the removal of duplicates,
10 articles together with 1 additional article identified
through hand-searching, were deemed eligible for inclu-
sion. Four articles were excluded due to the absence of
a reference population (n = 1), absence of prevalence
data (2) and inadequate sampling (2); thus seven articles
were included in the systematic review.
Summarised in Table 1 are the key design characteris-
tics of the included studies. The earliest published study
was conducted by Rush et al. (1979) [11], who reviewed
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Figure 1 Flow diagram of the article selection process.
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Page 3 of 9a large database of hospitals comprising the Western
Cape Peninsula maternity services, covering a 5 year
period. All included patients had been evaluated in the
tertiary cardiology clinic in consultation with an obste-
trician. The next report of antenatal heart disease was
published 20 years later, when Schoon et al. [12] col-
lected all cases of cardiac disease in pregnancy who had
delivered at Pelonomi Hospital (Bloemfontein) over 5
years. In 1999, Divanovic and Buchmann [13] performed
an audit of all deliveries referred over 2 months to the
tertiary obstetric unit of Chris Hani Baragwanath Hospi-
tal in Johannesburg. Their primary objective was to
assess whether routine heart and lung auscultation in
the clinic would increase the rate of diagnosis of cardiac
or pulmonary disease; however, they were able to esti-
mate the prevalence of heart disease as well.
Schoon later wrote a PhD thesis [14] based on his
initial observations on maternal heart disease in Bloem-
fontein. He undertook a prospective study over 2 years
of all maternal deaths and severe morbidity due to heart
disease, and then retrospectively screened all clinics and
hospitals in the region for records of patients with car-
diac disease who may have had uneventful deliveries
during that period. The main objective of his study was
to compare “complicated” cases of heart disease with
these uneventful deliveries. Another thesis paper that
met the inclusion criteria was published by Matlala [9],
who performed a chart review of all patients with heart
disease who delivered over a 3-year period at the Dr
George Mukhari Hospital in Ga-Rankuwa, Pretoria.
Similarly to the Schoon thesis, Matlala focused on
maternal and perinatal outcomes but reported epide-
miologic data as well.
Complementing the Matlala study, Soma-Pillay et al.
[10] conducted a review of a maternal registry at Pre-
toria Academic Hospital, another major referral center
in the Gauteng province of South Africa. This study was
conducted over 4 years. Finally, Nqayana et al. [15] per-
formed an audit of all cases of maternal heart disease
over 1 year at Inkosi Albert Luthuli Central Hospital in
Durban, which included a tertiary obstetric unit. Their
cohort also included patients referred from King Edward
VIII Hospital in Durban.
The data collected were almost exclusively retrospec-
tive and subject to a high degree of ascertainment bias.
Our summary of the prevalence and outcomes data
from the studies suggested that their highly variable
results (see Table 2) were probably due to large hetero-
geneity in study design and size of the included studies
(Table 1). Thus, although it was our original intention,
we did not perform a meta-analysis.
Epidemiology of heart disease in pregnancy
Table 2 contains data on the prevalence of antenatal
heart disease as measured in each study. Values ranged
from 123 to 943 per 100,000 deliveries, with a median
prevalence of 616 per 100,000 deliveries. Of note, we
excluded the “referred” sample of the Schoon thesis [14]
as these data were not gathered in a community-based
fashion and thus would have biased the results of the
“index” sample. Also, we had to contact the senior
author of the Nqayana et al. study [15] directly to obtain
estimates of the number of deliveries at the included
hospitals during that period, as these data were not
reported in the original manuscript. Of note, during the
review phase, we had a similar problem with a study on
mitral stenosis in pregnancy [16]; this manuscript was
Table 1 Characteristics of studies included in this review
Study ID (Year) Location Duration Study design n Diagnosis type
Rush et al. [11] Western Cape Province 5 yrs R, C 697 NS
Schoon et al. [12] Bloemfontein 5 yrs R, T 164 X/E
Divanovic and Buchmann [13] Johannesburg 2 mos R, T 3191 X
Schoon [14] Free State Province 2 yrs P, C 42 X/E
Matlala [6] Pretoria 3 yrs R, T 95 E
Soma-Pillay et al. [10] Pretoria 3 yrs R, T 189 X/E
Nqayana et al. [15] Durban 1 yrs R, T 95 E
yrs years, mos months, R retrospective, C community-based, T based at tertiary hospital, P prospective, X physical examination diagnosis, E echocardiographic
diagnosis, NS diagnostic method not specified. Diagnosis type refers to the techniques used to establish a final diagnosis in each patient. For example, in studies
labeled X/E, either physical examination or echocardiography was permitted to establish a diagnosis
Table 2 Prevalence of antenatal heart diseases; maternal
and perinatal outcomes
Study ID (Year) Prevalence Case-fatality
rate
Perinatal
mortality rate
Rush et al. [11] 834 717 8895
Schoon et al. [12] 587 9146 -
Divanovic and
Buchmann [13]
689 0 -
Schoon [14] 123 9524 23810
Matlala [6] 428 1980 9474
Soma-Pillay et al. [10] 943 3271 11640
Nqayana et al. [15] 616 0 9474
All figures are expressed per 100,000 deliveries and have been re-calculated
based on manuscripts’ raw data
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data and concerns over purposive sampling.
The included studies tended not to focus on clinical
history; however Schoon observed that the most com-
mon presenting symptoms of heart disease during the
antenatal period were dyspnoea and paroxysmal noctur-
nal dyspnoea [14]. Nqayana et al. remarked that 28 per
cent of their patients were previously unaware of their
cardiac condition [15], whereas Divanovic and Buch-
mann reported new diagnosis in only 8 per cent [13].
Table 3 presents the commonest types of cardiac
lesions found and their relative contribution to overall
disease burden. Valvular heart disease, principally rheu-
matic mitral stenosis, mitral regurgitation, and surgi-
cally-repaired mitral valves, were the commonest type of
lesions in all studies, ranging from 71 to 84 per cent.
The exception was Schoon’s thesis work [14], in which
valvular lesions comprised 33 per cent and cardiomyo-
pathies 55 per cent. Other studies reported cardiomyo-
pathies as a minor condition on the same order as
congenital disease, which ranged from 1 to 19 per cent
but typically less than 10 per cent. The prevalence of
“other” conditions ranged from 2 to 10 per cent and
included conditions such as arrhythmia, pericarditis, and
coronary disease, depending on the study.
Maternal and foetal outcomes
Our secondary objective was to conduct a qualitative
assessment of maternal and foetal outcomes. In the
included reports, outcomes varied greatly, were generally
centre-dependent, and improved over time. Case-fatality
rates and perinatal mortality rates are reported in Table
2. Case-fatality rates ranged from 0 to 9,524 per 100,000
deliveries. One study reported that mortality was signifi-
cantly higher in women with cardiac disease than in the
pregnant population overall (717 vs 46 per 100,000)
[11]. Of note, this was the only study that was con-
ducted prior to the human immunodeficiency virus
(HIV) era. Mitral stenosis, prosthetic valves, and cardio-
myopathies were most frequently associated with mater-
nal death [9-12], while isolated mitral regurgitation
typically had a benign course [15]. Throughout the stu-
dies, the most frequent causes of death were pulmonary
oedema, thrombosis or embolism, and haemorrhage,
typically in the setting of anticoagulant use.
Case-fatality rates were highest in the studies originat-
ing from the Free State [12,14] and lowest in the
Nqayana study [15] from Inkosi Albert Luthuli Central
Hospital in Durban. Nqayana et al. attributed their
superior outcomes to several factors, including the avail-
ability of percutaneous interventions, an intensive moni-
toring unit for pregnant women with cardiac disease,
and a multidisciplinary team of obstetricians and cardi-
ologists [15]. In the Free State, patients with isolated
mitral stenosis tended to have favorable outcomes, in
contrast to patients with cardiomyopathies. The study
authors attributed this finding to “aggressive” prophylac-
tic use of beta-blocking agents [12,14].
Maternal morbidity tended to follow globally estab-
lished patterns and clear relations to different cardiac
lesions. Decompensated heart failure was very common
in cardiomyopathies (2 of every 3 patients) [12] and ste-
notic mitral lesions [10]. In the latter study, Soma-Pillay
et al. reported pulmonary oedema in 84 per cent of
their “near-miss” cases and reinforced the need for rou-
tine intensive care unit monitoring of cardiac patients in
the peripartum period. Not surprisingly, even though
thrombosis and hemorrhage were not uniformly fatal,
they were common in all the studies and were thought
to be related in part to variable adherence to anticoagu-
lation as well as the intrinsic risks of warfarin use.
Schoon et al., in particular, noted a 17-fold increase in
maternal haemorrhage in patients on oral anticoagula-
tion for prosthetic valves [12]. Similarly, Nqayana et al.
reported 50 percent of patients with metalic valves had
problems related to anticoagulation [15].
We also collected data on perinatal mortality, which
ranged from 8,895 to 23,810 per 100,000 deliveries as
noted in Table 2. Again several trends were noted.
Firstly, antenatal heart disease is associated with a
higher rate of foetal loss than in pregnant women with-
out cardiac disease [9,11,15]. Furthermore, as Schoon
Table 3 Proportion of cases with major types of heart disease as diagnosed in each study
Study ID (Year) Native valve disease Prosthetic valve All valvular
disease
Cardiomyo-
pathies
Congenital disease Other
Rush et al. [11] 70 1 71 1 19 9
Schoon et al. [12] 58 19 77 18 1 4
Divanovic and Buchmann [13] 41 32 73 8 14 5
Schoon [14] 29 5 33 55 2 10
Matlala [6] 54 29 83 4 5 7
Soma-Pillay et al. [10] 63 20 84 6 9 2
Nqayana et al. [15] 60 21 81 3 9 6
All values are expressed as percentages
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highest perinatal mortality rates (19.3 per cent) when
compared with uneventful pregnancies (no perinatal
deaths noted) [14]. Secondly, mitral valve pathology
tended to carry the highest risk for the foetus. Matlala,
for example, noted a high incidence of low birth weight
(< 2,500 g) deliveries in patients either with native ste-
nosis or post mitral valve repair [9]; a finding that was
corroborated by Nqayana et al [15]. Thirdly, indiscrimi-
nate prescription of warfarin was associated with a sur-
prisingly high rate of foetal loss: Soma-Pillay et al.
reported a 30 percent versus 5 percent foetal loss in
mothers taking warfarin, presumably due to embryopa-
thy. They attributed this situation to the unfortunate
reality that most women taking warfarin are unaware of
their pregnancy, or at least could not obtain a booking
with a doctor until late in their first trimester after the
effects of warfarin had peaked [10]. This late discovery
of pregnancy was confirmed in Matlala’s cohort [9].
Psychosocial and public health aspects
Upon review of the studies, we found themes of poor
access to care and adherence across the studies. For
example, Schoon et al. noted a need for improved pre-
conception counseling as well as access to sterilisation
and contraception in mothers with a prior history of
heart disease. They also remarked that improved detec-
tion of cardiac lesions in the primary health clinics is an
“urgent priority” [12]. Similarly, Nqayana et al. stressed
a need for earlier referral to specialist cardiac care for
patients who are known to have cardiac conditions [15]
Soma-Pillay et al. reviewed their “near-misses” and
found that late booking, failure to book, and lack of
self-awareness of the patient’s condition were amongst
the root causes for morbidity [10]. Unbooked patients in
Matlala’s study also tended to present late in the third
trimester and with complications [9].
Self-assessment of study quality
Finally, study authors typically noted potential biases in
their research design, albeit inconsistently. Divanovic
and Buchmann remarked that their recruitment method
could have missed asymptomatic heart disease in the
community that had not been referred to the tertiary
hospital. They also speculated that undiagnosed heart
disease may be more prevalent in rural areas that were
not included in their study nor would have been as
likely to be referred [13]. Conversely, Matlala duly noted
the referral bias intrinsic in his maternal mortality calcu-
lations, as his study was conducted at a tertiary hospital
[9]. Soma-Pillay et al. similarly noted their referral bias
and also postulated (similarly to Divanovic and Buch-
mann) that some cases could have been missed [10].
Finally, in reporting the “population-based” prevalence
of antenatal heart disease, Schoon noted the assumption
that most women with heart disease seek care in the
public health sector (the data to which he had access).
He conceded that his recruitment method (based on
case reporting) could miss a substantial proportion of
cardiac disease that was asymptomatic or morbid but
otherwise unreported [14].
Discussion
We present the first systematic review of the burden of
heart diseases in the obstetric population in South
Africa. The unique nature of antenatal heart disease in
South Africa presents special challenges for public
health systems and clinical researchers alike.
The changing profile of antenatal heart disease
Our review identified a variety of studies conducted over
the past 30 years. Whilst the prevalence of antenatal
heart disease appears to have been stable since 1979, the
studies reviewed vary in their methods of diagnosis and
in the outcomes observed. The literature appears to
cover 3 distinct eras: the pre-HIV era, the 1990s prior
to intensive monitoring units and high usage of balloon
mitral valvuloplasty (BMV), and the present day. The
role of echocardiography has evolved over the decades;
in the earliest studies, echocardiography was not routi-
nely available for diagnosis, which was usually made
clinically or pathologically. In the modern era, echocar-
diography has become the standard of care and has
allowed for very detailed documentation of cardiac
lesions [15]. Regarding the role of the HIV/AIDS pan-
demic, no study has specifically investigated the interac-
tions between HIV infection and antenatal heart disease;
t h ee x c e p t i o nb e i n ga na n a l y s i sb yN q a y a n ae ta l .
demonstrating no difference in maternal or perinatal
outcome based on HIV positivity, or even advanced dis-
ease (CD4 count < 200 cells/ml) [15].
Maternal mortality in South Africa has been rising
over the past decade. Deaths due to HIV/AIDS, which is
thought to be a major contributing factor to overall
maternal mortality, increased 38 per cent from 2004 to
2007 [7,17]. Deaths from cardiac disease, however,
increased 31 per cent, suggesting that the antenatal
health system may be failing to detect and address the
problem. Recent reports on maternal mortality have
identified pervasive health systems failures such as lack
of accountability, poor quality of care, lack of medical
supplies and equipment, and endemic diseases them-
selves [6].
Comparison to other studies internationally
The studies reviewed bear many similarities to contem-
porary reports from other developing regions, as well as
differences to reports from industrialised nations.
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antenatal heart disease on the order of 1 per cent,
though there is some small variation by region [3,18].
Similar to other developing countries such as India [3],
Egypt [19], and Turkey [20], as well as Nigeria [21] and
Senegal [1],. the vast majority of cardiac lesions are
rheumatic in origin, consistently ranging from 80 to 95
per cent of cases in these studies. There is a contrast to
industrialised regions such as North America [18] and
Europe [22], where the vast majority of lesions are con-
genital, in keeping with the almost total eradication of
rheumatic heart disease from the Western world. How-
ever there is a uniquely high burden of cardiomyopathy
i ns u b - S a h a r a nA f r i c at h a ti sl e s sc o m m o ni no t h e r
developing regions [23], a finding that is reflected in the
studies reviewed (Table 3). Interestingly, studies from
the Free State province reported a peculiarly high rate
of cardiomyopathy even as compared with other pro-
vinces. The cause of this high rate is unclear and may
reflect either a true epidemiological pattern or differ-
ences in terminology or diagnostic criteria.
Also in contrast to developed [24] and other develop-
ing [3,19,20] regions, but in keeping with other parts of
sub-Saharan Africa [1], case fatality rates from antenatal
cardiac disease (particularly mitral lesions) were quite
high in South Africa, with a few exceptions. Rates were
especially high for studies conducted in the Free State,
which had a high proportion of rural cases as well as
less access to the percutaneous interventions that have
had great success in the referral hospitals in KwaZulu-
Natal. Supporting the important role of access to mitral
valve treatments, a prospective study of balloon mitral
valvuloplasty (BMV) at King Edward VIII Hospital in
Durban demonstrated no deaths out of 128 cases of
mitral stenosis in pregnancy [16], in contrast to Schoon
et al. in which 2 of 37 (5.4 per cent) of patients with
mitral stenosis died [12]. Also of note, anticoagulation-
related complications tended to be more common in
South African studies as compared to studies from
other developing regions, which report a high rate of
appropriate anticoagulation management [19] and low
prevalence of warfarin embryopathy [3]. This finding
has important implications for local management guide-
lines regarding the timing of surgical repairs, recom-
mendations for sterilisation, and choice of
anticoagulants during pregnancy, which remains a con-
troversial issue [9].
Limitations of the studies reviewed
The present review was greatly limited by heterogeneity
of the included studies, substantial biases in study
design, and inconsistencies in reporting. As noted above,
the most consistent data on cardiac diseases in pregnant
South African women come from tertiary institutions,
which carry an intrinsic referral bias particularly with
regard to the identification of severe cardiac disease and
a high risk of poor maternal and fetal outcomes. Thus
we report estimates of “prevalence” while conceding that
this term applies more appropriately to population-
based research. Similarly, we have shown that the profile
of antenatal heart disease has evolved over the past 3
decades, so we cannot be confident that these studies
represent estimates of the same “true” prevalence.
With regard to reporting inconsistencies, we note that
it was difficult for us to summarise details of cardiac
lesions and outcomes as their descriptions were highly
variable. For instance, some studies provided very fine
detail of individual mitral valve lesions [15] while others
simply reported the number of patients with “rheumatic
heart disease.” [10] Similarly, some studies [10,14]
grouped outcomes according to the “near-miss” system
[7], while others described outcomes in a meticulous case
report format [11,15]. At times, we were unclear as to
how diagnoses were made and the role of echocardiogra-
phy [12]. One limitation that prohibited meta-analysis of
our results was the unavailability of an exact baseline
number of deliveries at one study site [15], and although
the resulting estimate gave a prevalence consistent with
other studies, this could not be considered a rigorous epi-
demiological study. In our opinion, these inconsistencies
did not reflect individual study quality as much as the
divergent objectives of the included studies. Thus, for
future studies of antenatal heart disease that are con-
ducted in South Africa, we recommend a minimum set
of standardised reporting criteria as listed in Table 4.
At the systematic review level, we recognise that we
are not only limited by the data in the studies them-
selves, but also by incomplete retrieval. We attempted
to minimise this limitation by searching a wide variety
of databases, including one Africa-wide database and
two databases that focus on South African “grey” litera-
ture. Finally, there is a risk of reporting bias as some
scientific observations might not have been published in
indexed peer-reviewed journals.
Recommendations for future work
This review represents an important step in advancing
the science and clinical care of pregnant South Africans
with heart disease. We have recommended certain stan-
dards for future research in this area, as outlined in
Table 4. It is our hope that future studies on antenatal
heart disease in South Africa and elsewhere will adhere
to these recommendations and that these would ulti-
mately provide data suitable for meta-analysis. We also
offer our recommendations for other developing regions
that have a similar profile of antenatal heart disease.
However, as noted in the latest Confidential Enquiry
into maternal deaths in South Africa [7], better
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disease in pregnancy. Future guidelines will ideally be
informed by a better evidence base than currently exists,
taking into account the changing epidemiology of var-
ious lesions (and heart disease on the whole), new diag-
nostics and therapeutics, and psychosocial factors.
This study has a number of implications for policy,
practice and research. First, it is clear that the majority
of cases of antenatal heart disease in South Africa are
sequelae of group A streptococcal infection, i.e., RHD.
Control of rheumatic fever and RHD should be a top
priority for the South African Ministry of Health, com-
prising primary and secondary prevention efforts [25]. A
critical part of a comprehensive programme on RHD
would also include awareness-raising amongst pregnant
women: of their 27 new cardiac diagnoses, Nqayana et
al. found that 18 were of RHD [15]. Similarly, Desai et
al. found 42 per cent of their new diagnoses of (rheu-
matic) mitral stenosis were made during pregnancy [16].
Over time, prevention and education efforts could vastly
reduce the number of adult women with valve damage
and thus the absolute number of potentially morbid or
fatal pregnancies. An additional point of advocacy in the
field of child health relates to the consistent finding
that, of all lesions, (rheumatic) mitral lesions typically
confer the highest risk to the foetus [9,15,16].
Second, it is possible that screening for antenatal heart
disease might improve case detection at the primary
healthcare level and thus facilitate referral to specialist
care. Echocardiography-based screening of pregnant
women has been proposed as a potential modality, though
its cost-effectiveness is unclear [26,27]. B-type natriuretic
peptide has also been shown to be an effective biomarker
for cardiac disease in pregnant women and correlates with
adverse outcomes [28]. In light of the poor sensitivity of
auscultation and data that suggest it is ineffective for
screening in routine antenatal care [13], prospective stu-
dies are needed to determine the utility of alternative
screening modalities and their cost-effectiveness. Ideally, a
multicentre, prospective observational study of antenatal
heart disease in South Africa could be conducted at a
population level to simultaneously gather epidemiological
data (using echocardiography as a “gold standard”)a n d
assess several potential screening modalities.
Third, more clinical trials are needed to determine the
appropriate use of certain cardiac treatments during preg-
nancy. The evidence for BMV as a palliative measure
appears strong and percutaneous valve repair and replace-
ment seems to be on the horizon [29]. More rigorous trials
of medical strategies specific to the South African environ-
ment are needed, particularly to manage complications of
mitral stenosis such as atrial fibrillation and heart failure.
Perhaps most importantly, we have shown consistently
poor maternal and foetal outcomes for patients taking
warfarin during pregnancy. We believe that better anticoa-
gulation guidelines for pregnant women are needed and,
as part of this, newer and potentially less dangerous alter-
natives to warfarin [30] must be explored.
Finally, there remain substantial psychosocial barriers
and health disparities that need to be investigated and rec-
tified. Rheumatic heart disease is a disease of poverty [31]
and most of the pregnant women included in these studies
were of lower socioeconomic status. Women in such con-
ditions are less aware of their health and also, less empow-
ered to take care of themselves in terms of early booking
and adherence to medications, as noted above [10].
Conclusions
Heart disease affects at least 0.6 per cent of pregnant
women attending antenatal care in South Africa and
Table 4 Recommended minimum standards for future observational studies on antenatal heart disease in South Africa
Study parameters Examples
Basic study information to include
- Study design/recruitment methods
- Methods of diagnosis Clinical examination, echocardiogram, or algorithm
- Basic demographics Distribution by age and parity; proportion of pre-existing vs new diagnoses
- Data on the reference population Total number of deliveries at the institution during the study period
Profiling of cardiac lesions
- Detail valvular lesions MS, MR, mixed mitral, AS, AI, any prosthetic (metal vs biologic) repairs or BMV
- Detail congenital lesions Cyanotic, ASD, VSD (note any Eisenmenger syndrome)
- Detail cardiomyopathies Peri- or post-partum vs idiopathic dilated vs other cardiomyopathies
- Mention other lesions Arrhythmias (other than secondary AF), pericardial disease, coronary disease
Profiling of outcomes
- Stratify mortality by lesion Maternal death (include cause), foetal death (include cause if known)
- Stratify morbidity by lesion Pulmonary oedema, thrombosis, haemorrhage, infective endocarditis, IUGR, SGA
MS mitral stenosis, MR mitral regurgitation, AS aortic stenosis, AI aortic insufficiency, BMV balloon mitral valvuloplasty, ASD atrial septal defect, VSD ventricular
septal defect, AF atrial fibrillation, IUGR intrauterine growth restriction, SGA small for gestational age
Watkins et al. BMC Cardiovascular Disorders 2012, 12:23
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Page 8 of 9contributes to the persistently high maternal and perina-
tal mortality seen in this country. Rheumatic heart dis-
ease remains the predominant condition and often
results in adverse outcomes despite optimal manage-
ment. We have highlighted key limitations of the cur-
rent literature and have recommended minimum
reporting criteria for future studies in this area. Despite
the inherent management complexities of antenatal
heart disease, a renewed focus on these issues will
advance maternal and child health in South Africa.
Abbreviations
RHD: Rheumatic heart disease; HIV/AIDS: Human immunodeficiency virus/
acquired immune deficiency syndrome; BMV: Balloon mitral valvuloplasty
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